Federal Circuit Concludes Board Wrongly Declared Sanofi Patent Obvious
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on May 9 reversed a determination by the Patent Trial and Appeal Board that a patent directed to a drug delivery...To view the full article, register now.
Already a subscriber? Click here to view full article